The therapeutic potential of monoamine oxidase inhibitors
MBH Youdim, D Edmondson, KF Tipton - Nature reviews neuroscience, 2006 - nature.com
Monoamine oxidase inhibitors were among the first antidepressants to be discovered and
have long been used as such. It now seems that many of these agents might have …
have long been used as such. It now seems that many of these agents might have …
Drug addiction: the neurobiology of behaviour gone awry
ND Volkow, TK Li - Nature Reviews Neuroscience, 2004 - nature.com
Drug addiction manifests as a compulsive drive to take a drug despite serious adverse
consequences. This aberrant behaviour has traditionally been viewed as bad'choices' that …
consequences. This aberrant behaviour has traditionally been viewed as bad'choices' that …
Determinants of tobacco use and renaming the FTND to the Fagerström Test for Cigarette Dependence
K Fagerström - Nicotine & tobacco research, 2011 - academic.oup.com
Tobacco seems to have additional effects beyond nicotine. In the trivial sense, tobacco
smoke is made up of thousands of chemicals. The more interesting question is whether any …
smoke is made up of thousands of chemicals. The more interesting question is whether any …
Monoamine oxidases in age-associated diseases: New perspectives for old enzymes
Population aging is one of the most significant social changes of the twenty-first century. This
increase in longevity is associated with a higher prevalence of chronic diseases, further …
increase in longevity is associated with a higher prevalence of chronic diseases, further …
[HTML][HTML] Imaging the addicted human brain
JS Fowler, ND Volkow, CA Kassed… - Science & practice …, 2007 - ncbi.nlm.nih.gov
Modern imaging techniques enable researchers to observe drug actions and consequences
as they occur and persist in the brains of abusing and addicted individuals. This article …
as they occur and persist in the brains of abusing and addicted individuals. This article …
Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors
T Herraiz, C Chaparro - Biochemical and biophysical research …, 2005 - Elsevier
Monoamine oxidase (MAO) is a mitochondrial outer-membrane flavoenzyme involved in
brain and peripheral oxidative catabolism of neurotransmitters and xenobiotic amines …
brain and peripheral oxidative catabolism of neurotransmitters and xenobiotic amines …
Demonstration of isoleucine 199 as a structural determinant for the selective inhibition of human monoamine oxidase B by specific reversible inhibitors
Several reversible inhibitors selective for human monoamine oxidase B (MAO B) that do not
inhibit MAO A have been described in the literature. The following compounds: 8-(3 …
inhibit MAO A have been described in the literature. The following compounds: 8-(3 …
Functional brain imaging of tobacco use and dependence
AL Brody - Journal of psychiatric research, 2006 - Elsevier
While most cigarette smokers endorse a desire to quit smoking, only about 14% to 49% will
achieve abstinence after 6 months or more of treatment. A greater understanding of the …
achieve abstinence after 6 months or more of treatment. A greater understanding of the …
90 years of monoamine oxidase: some progress and some confusion
KF Tipton - Journal of Neural Transmission, 2018 - Springer
It would not be practical to attempt to deal with all the advances that have informed our
understanding of the behavior and functions of this enzyme over the past 90 years. This …
understanding of the behavior and functions of this enzyme over the past 90 years. This …
Is biological aging accelerated in drug addiction?
K Bachi, S Sierra, ND Volkow, RZ Goldstein… - Current opinion in …, 2017 - Elsevier
Highlights•Accelerated aging happens when biological age outpaces chronological age.•In
addiction the early-onset of comorbid diseases remains mostly undetected.•Oxidation …
addiction the early-onset of comorbid diseases remains mostly undetected.•Oxidation …